chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician's wife concerning a 16 year old female who on 25-FEB-2008 was vaccinated with the third dose of Gardasil (lot number: 659182/1757U). On approximately 27-FEB-2008 the patient experienced a hive-like eruption at the injection site within 48 hours post vaccination. It was reported by the physician's wife that the patient called the office on 27-FEB-2008 to report her symptoms and the patient was then treated with Benadryl 25mg and cold compress until the symptoms resolved. Subsequently, the patient recovered from hive-like eruption. No further information is available. This is in follow-up to report (s) previously submitted on 4/14/2008.  Follow-up information was received which indicated that the patient had received the 3rd dose of the GARDASIL and experienced a local reaction redness and swelling which lasted for 4 days.  No further information is available.
RLE DVT dx'd 4/16/2021, sx onset approx. 4/9/21.  Pt also c/o sharp stabbing pain between shoulder blades 2 days after 2nd moderna dose, lasted 4 days, resolved. and mild cough since then, persisting.
Information has been received from a Nurse Practitioner concerning a 73 year old male patient who on 09-MAR-2007 was vaccinated with his first dose of Pneumovax 23, lot #655668/1004F.  After receiving the injection the patient developed an injection site reaction described as redness, swelling, heat and pain on his entire arm.  The patient reported that his arm was so painful and swollen that he could not bend the arm.  He was seen in the office on 13-APR-2007 and still had forearm and hand redness, warmth, and mild swelling.  As of the report date the patient was recovering.  The reporter indicated that 2 other patients developed injection sit reactions after receiving Pneumovax 23 and requested a lot check be performed on lot #655668/1004F.  The records of testing prior to the release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency, and was released.  Additional information has been requested.
I did not have an adverse reaction to the vaccine. I had a runny nose and just thought I was getting a cold. I tested positive for COVID-19 on 01/28/2023 with extreme fatigue. I talked to my doctor, and I was offered the prescription for Paxlovid but I declined. I did have three separate infections after I recovered from COVID-19. I was on three separate antibiotics. As of today, I am feeling better with no lingering symptoms.
Moderna vaccine was administered - reported by patient  HYPOTENSION 8/26/2021 SLURRED SPEECH HYPOTENSION 8/26/2021 RECTAL CANCER HYPOTENSION 8/26/2021 CANCER METASTATIC TO LIVER
11-9-07 AM shot for flu - at injection felt as if given a double dose. Got sore that day. Next morn could not raise arm to side up. Back to doctor, given large dose of pain med. Didn't stop pain. Arm still in pain. As of 1-2-08 Arm still sore small amt of pain, but arm still not able to raise up to side or back without pain.
Bloody discharge from rectum; achy body; weak stomach; head cold; This spontaneous case was reported by a consumer and describes the occurrence of HAEMORRHOIDS (Bloody discharge from rectum), MYALGIA (achy body), ABDOMINAL PAIN UPPER (weak stomach) and NASOPHARYNGITIS (head cold) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 001A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced HAEMORRHOIDS (Bloody discharge from rectum), MYALGIA (achy body), ABDOMINAL PAIN UPPER (weak stomach) and NASOPHARYNGITIS (head cold). At the time of the report, HAEMORRHOIDS (Bloody discharge from rectum), MYALGIA (achy body), ABDOMINAL PAIN UPPER (weak stomach) and NASOPHARYNGITIS (head cold) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No concomitant medications reported. No treatment reported.
hemorrhagic proctitis occurred p/oral typhoid pills;resolved w/in 1-2 days of vax;It recurred about 4-5 days p/Bactrim then resolved w/another 3 days course o bactrim;
Client had dry cough and nausea . She was anxious after receiving first dose.  Reported not eating or drink any fluids since this morning
Patient states his left arm became fully numb, with the inability to move or grasp anything with his left hand. This started around 8am the day after his vaccination.
Chills; tiredness; periodic dry heaves over 2.5 day period; This is a spontaneous report from a non-contactable consumer or other non healthcare professional. A 62 year old female patient received bnt162b2 (BNT162B2), dose 3 via an unspecified route of administration on 06Nov2021 at 12:48 PM (Batch/Lot Number: FF2590) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced chills on an unspecified date with outcome of unknown, tiredness on an unspecified date with outcome of unknown and periodic dry heaves over 2.5 day period causing retching on an unspecified date with outcome of unknown.    No follow-up attempts are possible; No further information is expected.
BP; 170/110  mild SOB palpitation (HR 80bpm) hot flashes mild sweating  Took Claritin, increase fluid intake, and extra Valsartan x 1.
This spontaneous report as received from a nurse practitioner via company representative regarding a 17 year old female patient. The patient's pertinent medical history and concurrent conditions were not reported. On an unknown date the patient completed full series of GARDASIL lot, dosage regimen unknown as injection. Concomitant medications were not reported. On an unknown date the patient was diagnosed with mononucleosis. After post mononucleosis diagnosis several months later, the patient's mother complained to the nurse practitioner that the GARDASIL caused the patient to experience an unspecified rash and fatigue (onset date unknown). The patient did not seek medical attention and no treatment was given for the adverse events. The outcome of events was unknown. Product quality complaint (PQC) was not filed. Causality assessment was not provided. Additional information has been requested.
12/24/2021 I had Nasal Congestion, and on the 25th I lost my taste and smell followed by cough and fatigue. Symptoms lasted a good five days. I tested positive on the 25th.
An hour after receiving the first dose of the Moderna vaccine I experienced mild blurry vision. This lasted about 30 minutes then went away with no other problems.
15x10cm area of blanching erythema around injection site at L upper arm.  Started a few hours after injection- zero treatment included with systemic symptoms.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 23-JUN-2016, ZOSTAVAX was improperly exposed to a temperature of 14.36 F for 1.5 hours. Then on unspecified date in 2016, the patient was vaccinated with a improperly stored dose of ZOSTAVAX subcutaneous lot # L039096, expiration date 08-JAN-2017 (dose, dose number and anatomical location were not reported). No concomitant medications were reported. No adverse events were reported. Additional information has been requested.
Partial dose of vaccine (less than 1/2 dose) was given in error and repeat dose has been rescheduled per Guidelines.  No adverse effects of vaccine reported per RN. Pt scheduled for revaccination on 02-25-2021 @8:00AM
passed away; bubbles like blisters in the face/neck /back /arms / legs; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (passed away) and BLISTER (bubbles like blisters in the face/neck /back /arms /legs) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DEATH (passed away) (seriousness criteria death and medically significant) and BLISTER (bubbles like blisters in the face/neck /back /arms / legs) (seriousness criterion death). The reported cause of death was bubbles like blisters in the face/neck /back /arms / legs. It is unknown if an autopsy was performed.            Concomitant products were not provided.  Treatment medication were not reported. Patient was healthy in his 80s. The patient had bubbles like blisters in the face and in the back of the neck, back and arms, and legs.  This is a case of death in a 80-year-old male patient after receiving vaccine. The patient also experienced blisters in the face and in the back of the neck, back and arms, and legs. Very limited information has been provided at this time.; Sender's Comments: This is a case of death in a 80-year-old male patient after receiving vaccine. The patient also experienced blisters in the face and in the back of the neck, back and arms, and legs.Very limited information has been provided at this time.; Reported Cause(s) of Death: passed away; bubbles like blisters in the face/neck /back /arms / legs
3 hours after taking the vaccine and then both arms from elbows to finger tips started shaking wildly which lasted about 30 secs then it stopped. Had a big lump on her hairline which was .
Fatigued; Dizzy; when the vertigo hits, I'm down; 3-4 episodes of vertigo on Thursday; have had headache since then; almost fell down a flight of stairs; Stood up and fell down; headache at the back of my head; 6 episodes of vertigo on Wednesday; threw up twice after 1st episode of vertigo; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Stood up and fell down), INJECTION SITE PAIN (Arm was sore), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday) and VOMITING (threw up twice after 1st episode of vertigo) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lymphoma. Concomitant products included DULOXETINE and OMEPRAZOLE for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INJECTION SITE PAIN (Arm was sore). On 03-Mar-2021, the patient experienced FALL (Stood up and fell down), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday), VOMITING (threw up twice after 1st episode of vertigo), HEADACHE (have had headache since then) and FALL (almost fell down a flight of stairs). On 04-Mar-2021, the patient experienced VERTIGO (3-4 episodes of vertigo on Thursday). On 05-Mar-2021, the patient experienced FATIGUE (Fatigued), DIZZINESS (Dizzy) and VERTIGO (when the vertigo hits, I'm down). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FALL (Stood up and fell down), INJECTION SITE PAIN (Arm was sore), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday), VOMITING (threw up twice after 1st episode of vertigo), FATIGUE (Fatigued), DIZZINESS (Dizzy), HEADACHE (have had headache since then), FALL (almost fell down a flight of stairs), VERTIGO (3-4 episodes of vertigo on Thursday) and VERTIGO (when the vertigo hits, I'm down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Family stated that patient was vaccinated x2 for COVID but has not received the booster. Unable to obtain information on manufacturer or dates of vaccinations. Pt hospitalized for altered mental status and has tested positive for COVID
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 22-APR-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number reported as R021930 with expiration date in 18-JUN-2020) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  Lot number R021930 is an invalid lot number for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001848: US-009507513-1907USA001849: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001841: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001842: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000962: US-009507513-1907USA000988: US-009507513-1907USA000963: US-009507513-1907USA000953: US-009507513-1907USA000959: US-009507513-1907USA000968: US-009507513-1907USA000967: US-009507513-1907USA000964: US-009507513-1907USA000966: US-009507513-1907USA000954: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000965:
Patient called and said arm where Pneumococcal vaccine given was very sore, swelling & pain. Could hardly use arm for 3 days. Then was ok.
Patient was expecting to receive the Pfizer Bivalent vaccine and instead received the Pfizer monovalent. There have been no ADRs as a result. The patient was consulted on the proper process for this error via CDC recommendations ( fully vaccinated, may get bivalent in 2 months).
Information has been received from a medical assistant concerning a 22 year old female with no drug allergies and no medical history, who on 09-AUG-2007 was vaccinated with a 0.5mL second dose of Gardasil (Lot# 658222/0927U). Concomitant therapy included loratadine and ORTHO TRI-CYCLEN. On 09-AUG-2007 the patient felt odd, felt tingling on whole arm of the injection site and the patient felt the medication traveling down her arm. The medical assistant reported that the patient felt hot, nauseated, and she became pale immediately after receiving the vaccination. No laboratory diagnostics were performed. The patient did not seek medical attention. On 09-AUG-2007 the patient recovered. No product quality complaint was involved. Additional information has been requested.
Within a week I developed neck discomfort lasted 2 weeks. I have a history of thyroid cancer therefore I was referred to specialist which performed test. The doctor stated the vaccine was  the reason for the  swollen lymph nodes on left side of neck.
5 days after shot (shot on Mar 9), breastmilk supply dropped dramatically for 2 days (Mar 14 & 15). Moderately increased Mar 16 & back to normal by Mar 17. No other changes to pumping schedule or feedings.
pt recv vax 16JUL96 & 3AUG96 pt exp diffuse, stinging sensation of the skin, all over body;
-Red itchy neck about an 1 hour after shot.  Lasted about 30 minutes.  - 30 hours later I got itchy rash on arm with tiny bumps. Took an antihistamine and rash subsided  soon after
Child with two brief (1-2 minutes) generalized seizures associated with fever 104 F.
blurred/slowed vision, head pressure, ear pressure, sinus pressure, eye pain, ear pain, tinnitus, anxiety
Patient reported a bloody nose that she could not get to stop for approximately 3 minutes.  After the bloody nose stopped, patient reported feeling light headed and passed out for approximately 10 seconds.
parotid swelling x 1day, tender lt ear pain;given ATB x 10 days;resolved;
Pains initially, arms swelling radiating to shoulder and chest, blood pressure elevated, stomach cramping.
Initial report received on 06-November-2013 from a health care professional. A 10-year-old male patient whose medical history included attention deficit hyperactivity disorder (ADHD) and concomitant medications were not reported, received a dose of FLUZONE (lot number U4789AA) via intramuscular route at left deltoid on  06-Nobember 2013. On 06-November-2013, 1 hour post vaccination the patient experienced headache. Corrective treatment included ibuprofen. At the time of this report the outcome of  headache was resolving. List of documents held by sender: none.
10 days of intermittent moderate to severe headaches; nausea; muscle aches; joint pain; chills; moderate to severe fatigue which the fatigue was intermittent; unrelieved with anti-nausea medication or Tylenol and ibrofen. I missed 4 days of work.  After about 14 -21 I felt recovered except for mild fatigue. Unable to return to baseline activity of running 5 days a week and surfing on weekends.
1 week after receiving the vaccine, I developed a rash around the injection site that was warm to the tough, and was itchy.  It?s been 2 days since that started and now the rash is the size of my hand.
ON 04/29/2021 HEAVY INDEGESTION, CHEST PAINS ACROSS FULL CHEST,  CHILLS, FEVER 98-100 DEGREE RANGE SPENT 36 HRS IN HOSPITAL DID CARDIAC STRESS TEST AND LUNG IMAGING, DISCOVERED SWELLING IN NOGILES REALEASED ON THE 31st.
Extreme pain on arm, unable to lift it or use it without extreme pain. Dr. ordered MRI of arm and shoulder. Almost 4 weeks since vaccine given, cannot use left arm at - all.
Presented to ED with history of chronic respiratory failure with COPD and CHF- presented with shortness of breath, he was found to have no rhonchi or wheezing but he was found to have pulmonary edema from left ventricular heart failure. Patient admitted. He was diuresing watching his kidney function and urine output, his oxygen requirement has come to his baseline-that is treated per minute. He has no chest pain or shortness of breath, no reason to suspect PE. Troponin negative. Patient stable for discharge.
severe chills, fever of 102, joint pain, body aches, splitting headache, nausea, vomiting, dizziness, weakness, significant fatigue, day one, day two chills, fever of 101, joint pain, body aches, headache, nausea, dizziness, fatigue, diarrhea, very dark colored urine, day three temperature down to 98.9 in the morning and 97.5 by end of day, fatigue and slight dizziness, dark colored urine. By day 4 still a bit nauseous, but all other symptoms gone
Swelling & redness at site, bleeding & blood under the skin. Area became hard but only spread to a diameter of 1-2 inches. Pt wanted to put ice on site & come later for injection.
Evening of injections got fussy, then had generalized fine shaking. Prior to shaking had episode where she straightened out. Spell lasted less than 2 minutes, no color change. Vomited x 3 on way to hospital. Crying after episode. Temp 102.6F in ER.
unwell; Swelling of mole on left elbow/Increased size of a mole on left elbow/now swelling, size has grown as a quarter/ mole described as size as a little pebble; Feels very weak; Hot to touch left elbow; Fatigue; Headache; Musclepain; Swelling at injection site; Hot to touch injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (unwell), MELANOCYTIC NAEVUS (Swelling of mole on left elbow/Increased size of a mole on left elbow/now swelling, size has grown as a quarter/ mole described as size as a little pebble), ASTHENIA (Feels very weak), VACCINATION SITE WARMTH (Hot to touch injection site) and JOINT WARMTH (Hot to touch left elbow) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic (levoquine), Drug allergy (narcus), Allergy to antibiotic (microbid), Allergy to antibiotic (clindamycin), Drug allergy (lyrica), Drug allergy (haldol) and Drug allergy (ketamine).    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch injection site) and VACCINATION SITE SWELLING (Swelling at injection site). On 14-Aug-2021, the patient experienced MELANOCYTIC NAEVUS (Swelling of mole on left elbow/Increased size of a mole on left elbow/now swelling, size has grown as a quarter/ mole described as size as a little pebble), ASTHENIA (Feels very weak), JOINT WARMTH (Hot to touch left elbow), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Musclepain). On an unknown date, the patient experienced MALAISE (unwell). On 13-Aug-2021, VACCINATION SITE WARMTH (Hot to touch injection site) and VACCINATION SITE SWELLING (Swelling at injection site) had resolved. At the time of the report, MALAISE (unwell), MELANOCYTIC NAEVUS (Swelling of mole on left elbow/Increased size of a mole on left elbow/now swelling, size has grown as a quarter/ mole described as size as a little pebble), ASTHENIA (Feels very weak), JOINT WARMTH (Hot to touch left elbow), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Musclepain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Aug-2021: Significant follow-up received contains: added events-fatigue, headache, muscle pain, asthenia,malaise